Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease (Q48377970)

11 February 2018

title

Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease (English)

1 reference

11 February 2018

1 reference

1 reference

Michele Morari

1

1 reference

11 February 2018

Martina Fantin

series ordinal

2

1 reference

11 February 2018

publication date

1 June 2015

1 reference

11 February 2018

published in

Analyst

1 reference

11 February 2018

volume

140

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

3830-3839

1 reference

11 February 2018

Neostriatal mechanisms in Parkinson's disease

cites work

1 reference

Rationale for and use of NMDA receptor antagonists in Parkinson's disease.

21 January 2018

1 reference

N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease

21 January 2018

1 reference

Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia

21 January 2018

1 reference

The role of striatal NMDA receptors in drug addiction

21 January 2018

1 reference

Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat.

21 January 2018

1 reference

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

21 January 2018

1 reference

NMDA receptor subunits: function and pharmacology.

21 January 2018

1 reference

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

21 January 2018

1 reference

Diversity in NMDA receptor composition: many regulators, many consequences

21 January 2018

1 reference

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 January 2018

1 reference

Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus

21 January 2018

1 reference

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

21 January 2018

1 reference

Control of basal ganglia output by direct and indirect pathway projection neurons.

21 January 2018

1 reference

The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns

21 January 2018

1 reference

Concurrent activation of striatal direct and indirect pathways during action initiation.

21 January 2018

1 reference

Differential innervation of direct- and indirect-pathway striatal projection neurons.

21 January 2018

1 reference

Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum

21 January 2018

1 reference

Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism

21 January 2018

1 reference

NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways

21 January 2018

1 reference

GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats

21 January 2018

1 reference

Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor f

21 January 2018

1 reference

Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--I. Effects of perfusion with tetrodotoxin and low-calcium medium

21 January 2018

1 reference

Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat.

21 January 2018

1 reference

The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K( )-depolarization, lesions and peptidase inhibition

21 January 2018

1 reference

Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors

21 January 2018

1 reference

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

21 January 2018

1 reference

The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.

21 January 2018

1 reference

Inhibitory control of neostriatal projection neurons by GABAergic interneurons

21 January 2018

1 reference

Target selectivity of feedforward inhibition by striatal fast-spiking interneurons.

21 January 2018

1 reference

Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice.

21 January 2018

1 reference

Contribution of different classes of glutamate receptors in the corticostriatal polysynaptic responses from striatal direct and indirect projection neurons

21 January 2018

1 reference

N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol

21 January 2018

1 reference

Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery

21 January 2018

1 reference

In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions

21 January 2018

1 reference

Short-term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system

21 January 2018

1 reference

Spontaneous synaptic potentials in dopamine-denervated neostriatal neurons

21 January 2018

1 reference

Striatal Spine Plasticity in Parkinson's Disease

21 January 2018

1 reference

Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.

21 January 2018

1 reference

Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.

21 January 2018

1 reference

Striatal microcircuitry and movement disorders

21 January 2018

1 reference

Dopamine-deprived striatal GABAergic interneurons burst and generate repetitive gigantic IPSCs in medium spiny neurons.

21 January 2018

1 reference

Dopamine-mediated regulation of corticostriatal synaptic plasticity.

21 January 2018

1 reference

Striatal plasticity and basal ganglia circuit function

21 January 2018

1 reference

Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated

21 January 2018

1 reference

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid

21 January 2018

1 reference

Striatal dopamine and glutamate release: effects of intranigral injections of substance P

21 January 2018

1 reference

Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis

21 January 2018

1 reference

MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats

21 January 2018

1 reference

Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons

21 January 2018

1 reference

Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat

21 January 2018

1 reference

Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.

21 January 2018

1 reference

Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity

21 January 2018

1 reference

The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis

21 January 2018

1 reference

Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway

21 January 2018

1 reference

Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.

21 January 2018

1 reference

Neurotransmitter Corelease: Mechanism and Physiological Role

21 January 2018

1 reference

Stimulation of delta opioid receptors located in substantia nigra reticulata but not globus pallidus or striatum restores motor activity in 6-hydroxydopamine lesioned rats: new insights into the role of delta receptors in parkinsonism

21 January 2018

1 reference

Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.

21 January 2018

1 reference

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

21 January 2018

1 reference

Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system.

21 January 2018

1 reference

A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia

21 January 2018

1 reference

Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease

21 January 2018

1 reference

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

21 January 2018

1 reference

A novel family of negative and positive allosteric modulators of NMDA receptors.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/C4AN01918K

1 reference

11 February 2018

1 reference

11 February 2018